Ann Arbuck
MD
Senior Investigator
👥Biography 个人简介
The National Cancer Institute Common Terminology Criteria for Adverse Events (CTCAE) provides standardized terminology and severity grading for adverse events in cancer clinical trials and clinical practice. NCI CTCAE — widely used in oncology trials worldwide — enables consistent comparison of toxicity across trials and institutions and is essential for safety reporting in cancer drug development and post-marketing surveillance.
🧪Research Fields 研究领域
🎓Key Contributions 主要贡献
Representative Works 代表性著作
📄Data Sources 数据来源
Last updated: 2026-03-01 | All information from publicly available academic sources
Related Experts 相关专家
Antoni Ribas
UCLA Jonsson Comprehensive Cancer Center
Drew M. Pardoll
Johns Hopkins University
Padmanee Sharma
MD Anderson Cancer Center
Naiyer A. Rizvi
Columbia University Irving Medical Center
关注 Ann Arbuck 的研究动态
Follow Ann Arbuck's research updates
留下邮箱，当我们发布与 Ann Arbuck（National Cancer Institute）相关的新研究或访谈时，我们会通知你。
Explore More Experts
Discover the researchers shaping the future of cancer treatment